This is a brief overview of the structural, biophysical and pharmacological properties …

• Abstract
• Text
• References

Biology Articles » Biophysics » Liposomes: from biophysics to the design of peptide vaccines » References

References

- Liposomes: from biophysics to the design of peptide vaccines

1. Ostro MJ (1987). Introduction. In: Ostro MJ (Editor), Liposomes: from Biophysics to Therapeutics. Marcel Dekker, Inc., New York and Basel.   

2. New RRC (1990). Introduction. In: New RRC (Editor), Liposomes - a Practical Approach. IRL Press, Oxford, New York, Tokyo.  

3. Allison AC & Gregoriadis G (1974). Liposomes as immunological adjuvants. Nature, 252: 252.  

4. Gregoriadis G (1990). Immunological adjuvants: a role for liposomes. Immunology Today, 11: 89-97.   

5. Alving CR (1991). Liposomes as carriers of antigens and adjuvants. Journal of Immunological Methods, 140: 1-13.    

6. Gregoriadis G (1993). Liposome as immunological adjuvants for peptide and protein antigens. In: Gregoriadis G, Florence AT & Patel AM (Editors), Liposomes in Drug Delivery. Harwood Academic Publishers, Switzerland. 

7. Kersten GFA & Crommelin DJA (1995). Liposomes and ISCOMS as vaccine formulations. Biochimica et Biophysica Acta, 1241: 117-138. 

8. Gregoriadis G (1995). Engineering liposomes for drug delivery: progress and problems. Trends in Biotechnology, 13: 527-537. 

9. Connor J, Yatvin M & Huang L (1984). PH-sensitive liposomes: acid induced fusion. Proceedings of the National Academy of Sciences, USA, 81: 1715-1720.  

10. Legendre J-Y & Szoka Jr FC (1995). Liposomes for gene therapy. In: Puisieux F, Couvreur P, Delattre J & Devissaguet JP (Editors), Liposomes, New Systems and New Trends in Their Applications. Editions de Santé, France.   

11. Crowe JH, Hoekstra FA & Crowe LM (1992). Anhydrobiosis. Annual Review of Physiology, 54: 579-599.

12. Allen TM, Hong K & Papahadjopoulos D (1990). Membrane contact fusion and hexagonal (HII) transitions in phosphatidyl ethanolamine liposomes. Biochemistry, 29: 2976-2985. 

13. Gregoriadis G (1993). Liposome Technology. 2nd edn. CRC Press Inc., Boca Raton, FL. 

14. Friede M, van Regenmortel MHV & Schuber F (1993). Lyophilized liposomes and shelf items for the preparation of immunogenic liposome-peptide conjugates. Analytical Biochemistry, 211: 117-122.

15. Szoka F & Papahadjopoulos D (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proceedings of the National Academy of Sciences, USA, 75: 4194-4198. 

16. Kirby C & Gregoriadis G (1984). Dehydration-rehydration vesicles: a simple method for high yield drug entrapment in liposomes. Biotechnology, 2: 979-984.    

17. Shew RL & Deamer DW (1985). A novel method for encapsulation of macromolecules in liposomes. Biochimica et Biophysica Acta, 816: 1-8. 

18. Tan L, Loyter A & Gregoriadis G (1989). Incorporation of reconstituted influenza virus envelopes into liposomes: studies of the immune response in mice. Biochemical Society Transactions, 17: 129-130.  

19. Freitas TV & Frézard F (1997). Encapsulation of native crotoxin in liposomes: a safe approach for the production of antivenom and vaccination against Crotalus durissus terrificus venom. Toxicon, 35: 91-100. 

20. Frézard F, Toledo VPCP, Elias RM, Tavares CAP, Da Costa CA, Genaro O & Mayrink W (1995). Vaccination of C57BL/10 mice against cutaneous leishmaniasis by liposome-encapsulated antigens. Memórias do Instituto Oswaldo Cruz, 90 (Suppl I): 194 (Abstract IM-091). 

21. Brunner J, Skrabal P & Hauser H (1976). Single bilayer vesicles prepared without sonication. Physico-chemical properties. Biochimica et Biophysica Acta, 455: 322-331.  

22. Frézard F, Santaella C, Montisci MJ, Vierling P & Riess JG (1994). Fluorinated phospholipid-based liposomes: H⁺/Na⁺ permeability, active doxorubicin encapsulation and stability in human serum. Biochimica et Biophysica Acta, 1194: 61-68.  

23. Riess JG, Frézard F, Greiner J, Kraft MP, Santaella C, Vierling P & Zarif L (1995). Membranes, vesicles and other supramolecular systems made from fluorinated amphiphiles. In: Barenholz Y & Lasic D (Editors), Handbook of Non-Medical Applications of Liposomes.CRC Press Inc., Boca Raton, FL. 

24. Frézard F, Santaella C, Vierling P & Riess JG (1994). Permeability and stability in buffer and in human serum of fluorinated phospholipid-based liposomes. Biochimica et Biophysica Acta, 1192: 61-70.

25. Fattal E, Ramaldes GA & Ollivon M (1995). Oral delivery of vaccines by means of liposomes. In: Puisieux F, Couvreur P, Delattre J & Devissaguet JP (Editors), Liposomes, New Systems and New Trends in Their Applications. Editions de Santé, France. 

26. Crowe LM, Crowe JH, Rodolph A, Womersley C & Appel L (1985). Preservation of freeze-dried liposomes by trehalose. Archives of Biochemistry and Biophysics, 242: 240-247. 

27. Crowe LM & Crowe JH (1995). Freeze-dried liposomes. In: Puisieux F, Couvreur P, Delattre J & Devissaguet JP (Editors), Liposomes, New Systems and New Trends in Their Applications. Editions de Santé, France. 

28. Devine DV & Marjan JMJ (1997). The role of immuno-proteins in the survival of liposomes in the circulation. Critical Reviews in Therapeutic Drug Carrier Systems, 14: 105-131. 

29. Liu F & Liu D (1996). Serum independent liposome uptake by mouse liver. Biochimica et Biophysica Acta, 1278: 5-11. 

30. Oussoren C, Zuidema J, Crommelin DJ & Storm G (1997). Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid dose. Biochimica et Biophysica Acta, 1328: 261-272.    

31. Lasic DD & Papahadjopoulos D (1995). Liposomes revisited. Science, 267: 1275-1276.   

32. Santaella C, Frézard F, Vierling P & Riess JG (1993). Extended in vivo blood circulation time of fluorinated liposomes. Federation of European Biochemical Societies Letters, 336: 481-484.  

33. Gupta RK, Varanelli CL, Griffin P, Wallach DF & Sibber GR (1997). Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens. Vaccine, 14: 219-225.   

34. Nakanishi T, Kunisawa J, Hayashi A, Tsutsumi Y, Kubo K, Nakagawa S, Fujiwara H, Hamaoka T & Mayumi T (1997). Positively charged liposomes function as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochemical and Biophysical Research Communications, 240: 793-797. 

35. Reddy R, Zhou F, Nair S, Huang L & Rouse BT (1992). In vivo cytotoxic T lymphocytes induction with soluble proteins administered in liposomes. Journal of Immunology, 148: 1585-1589. 

36. Cohen S & Langer R (1995). Long-term protein delivery from microencapsulated liposome systems. In: Puisieux F, Couvreur P, Delattre J & Devissaguet JP (Editors), Liposomes, New Systems and New Trends in Their Applications. Editions de Santé, France.  

37. Gregoriadis G (1998). Genetic vaccines: strategies for optimization. Pharmaceutical Research, 15: 661-670.